annb0t
Top 20
ResMed Inc.âs RMD adjusted earnings per share (EPS) for the third quarter of fiscal 2024 were $2.13, up 26.8% year over year. The metric beat the Zacks Consensus Estimate by 10.9%.
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, restructuring and masks with magnet field safety notification expenses, among others.
GAAP EPS in the reported quarter was $2.04, up 29.1% from the year-ago quarter.
Revenues
On a reported basis, fis...
>>> Read more: ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, restructuring and masks with magnet field safety notification expenses, among others.
GAAP EPS in the reported quarter was $2.04, up 29.1% from the year-ago quarter.
Revenues
On a reported basis, fis...
>>> Read more: ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand
